IL-17 family cytokines and the expanding diversity of effector T cell lineages

Annual Review of Immunology

Volumn 25, Issue , 2007, Pages 821-852

  Weaver, Casey T ^a,b   Hatton, Robin D ^a   Mangan, Paul R ^b   Harrington, Laurie E ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adaptive immunity; IL 17; IL 23; IL 25; IL 27; IL 6; Innate immunity; TGF ; Th1; Th17; Th2

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 27;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL LINEAGE; CELL MATURATION; CELLULAR IMMUNITY; COMPREHENSION; CYTOLOGY; DATA BASE; EDUCATION; EFFECTOR CELL; HOST RESISTANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; MODEL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-12; INTERLEUKIN-17; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TH1 CELLS; TH2 CELLS;

EID: 33847206969     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.25.022106.141557     Document Type: Review

References (134)

1. H2 model: a personal perspective. Nat. Immunol. 7:539-41
2. Sredni B, Tse HY, Schwartz RH. 1980. Direct cloning and extended culture of antigen-specific MHC-restricted, proliferating T lymphocytes. Nature 283:581-83
3. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-57
4. Coffman RL, Carty J. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol. 136:949-54
5. Mosmann TR, Coffman RL. 1987. Two types of mouse helper T-cell clone. Immunol. Today 8:223-27
6. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. 1988. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168:543-58
7. Gajewski TF, Fitch FW. 1988. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245-52
8. Mosmann TR, Coffman R. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-73
9. Finkelman FD, Shea-Donohue T, Goldhill J, Sullivan CA, Morris SC, et al. 1997. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu. Rev. Immunol. 15:505-33
10. + T cells. J. Immunol. 139:1303-9
11. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72
12. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-84
13. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065-69
14. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-98
15. + αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:371-82
16. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, et al. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-45
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-49
18. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188-92
19. + T cells. Annu. Rev. Immunol. 12:635-73
20. Murphy KM, Reiner SL. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933-44
21. Boulay JL, O'Shea JJ, Paul WE. 2003. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 19:159-63
22. + T cells. Immunity 16:779-90
23. + T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100:15047-52
24. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. 2003. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12Rβ2 in naive T cells. J. Interferon Cytokine Res. 23:513-22
25. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-69
26. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-10
27. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, et al. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-81
28. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548-55
29. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-96
30. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, et al. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745-55
31. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, et al. 2000. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12:27-37
32. Pai SY, Truitt ML, Ho IC. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 101:1993-98
33. Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugava K, Hosokawa H, et al. 2004. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279:26983-90
34. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, et al. 2004. Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses. Nat. Immunol. 5:1157-65
35. Min B, Prout M, Hu-Li J, Zhu JF, Jankovic D, et al. 2004. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J. Exp. Med. 200:507-17
36. Shinkai K, Mohrs M, Locksley RM. 2 002. Helper T cells regulate type-2 innate immunity in vivo. Nature 420:825-29
37. + bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin. J. Immunol. 147:903-9
38. + T cells in a TH2 response and in immunoglobulin E production. Science 270:1845-47
39. Voehringer D, Reese T, Huang X, Shinkai K, Locksley RM. 2006. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 203:1435-46
40. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. 1993. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:5445-56
41. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, et al. 1995. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811-21
42. Kolls JK, Linden A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-76
43. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985-95
44. Pancer Z, Cooper MD. 2006. The evolution of adaptive immunity. Annu. Rev. Immunol. 24:497-518
45. Gunimaladevi I, Savan R, Sakai M. 2006. Identification, cloning and characterization of interleukin-17 and its family from zebrafish. Fish Shellfish Immunol. 21:393-403
46. Khalturin K, Panzer Z, Cooper MD, Bosch TC. 2004. Recognition strategies in the innate immune system of ancestral chordates. Mol. Immunol. 41:1077-87
47. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, et al. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20:5332-41
48. Moseley TA, Haudenschild DR, Rose L, Reddi AH. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-74
49. Tian E, Sawyer JR, Largaespada DA, Jenkins NA, Copeland NG, Shaughnessy JD Jr. 2000. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 19:2098-109
50. Haudenschild D, Moseley T, Rose L, Reddi AH. 2002. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J. Biol. Chem. 277:4309-16
51. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-27
52. Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, et al. 2000. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275:19167-76
53. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, et al. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276:1660-64
54. Kramer JM, Yi L, Shen F, Maitra A, Jiao X, et al. 2006. Evidence for ligand-independent multimerization ofthe IL-17 receptor. J. Immunol. 176:711-15
55. Yao Z, Spriggs MK, Deny JM, Strockbine L, Park LS, et al. 1997. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9:794-800
56. Toy D, Kugler D, Wolfson M, Bos TV, Gurgel J, Deny J, Tocker J, Peschon J. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177:36-39
57. Schwandner R, Yamaguchi K, Cao Z. 2000. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191:1233-40
58. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677-88
59. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-2 3 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432-36
60. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170:2106-12
61. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285-94
62. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. 2002. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169:642-46
63. Li H, Chen J, Huang A, Stinson J, Heldens S, et al. 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97:773-78
64. Moore EE, Presnell S, Garrigues U, Guilbot A, LeGuern E, et al. 2002. Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease. Neuromuscul. Disord. 12:141-50
65. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, et al. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155:5483-86
66. McKenzie BS, Kastelein RA, Cua DJ. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27:17-23
67. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, et al. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-87
68. Nakae S, Nambu A, Sudo K, Iwakura Y. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173-77
69. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, et al. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169:443-53
70. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107-15
71. Hunter CA. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5:521-31
72. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-25
73. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-14
74. Constantinescu CS, Wysocka M, Hilliard B, Ventura ES, Lavi E, et al. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161:5097-104
75. Leonard JP, Waldburger KE, Goldman SJ. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-86
76. Segal BM, Dwyer BK, Shevach EM. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:537-46
77. Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher LH, Kuchroo VK. 2004. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200:79-87
78. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, et al. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5-7
79. Kageyama Y, Koide Y, Yoshida A, Uchijima M, Arai T, et al. 1998. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-γ receptor. J. Immunol. 161:1542-48
80. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Billiau A. 1998. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-γ receptor-deficient mice. Eur. J. Immunol. 28:2143-51
81. + myeloid cells. J. Immunol. 163:3503-10
82. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223-27
83. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-48
84. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, et al. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-57
85. Zhang GX, Gran B, Yu S, Li J, Siglienti I, et al. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170:2153-60
86. Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167:141-49
87. Lubberts E, Joosten LAB, Oppers B, van den Bersselaar L, Coenen-de Roo CJJ, et al. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167:1004-13
88. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJJ, et al. 2004. Treatment with a neutralizing antimurine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50:650-59
89. Koenders MT, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, et al. 2005. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 52:975-83
90. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-40
91. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, et al. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116:1317-26
92. Bettelli E, Kuchroo VK. 2005. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J. Exp. Med. 201:169-71
93. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-32
94. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-41
95. Lovett-Racke AE, Rocchini AE, Choy J, Northrop SC, Hussain RZ, et al. 2004. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21:719-31
96. Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, et al. 2001. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108:739-47
97. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-89
98. H17 lineage. Nature 441:231-34
99. H17 and regulatory T cells. Nature 441:235-38
100. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. 2006. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 11:1151-56
101. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. 2004. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173:7249-58
102. + T cell-mediated suppression by dendritic cells. Science 299:1033-36
103. Wahl SM. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-90
104. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91
105. Dinarello CA. 1999. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103:11-24
106. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. 2001. IL-18-stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2:157-64
107. Nakahira M, Tomura M, Iwasaki M, Ahn HJ, Bian Y, et al. 2001. An absolute requirement for STAT4 and a role for IFN-γ as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex. J. Immunol. 167:1306-12
108. + T cells. Nat. Immunol. 3:549-57
109. Gutcher I, Urich E, Wolter K, Prinz M, Becher B. 2006. Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat. Immunol. 7:946-53
110. Shi FD, Takeda K, Akira S, Sarvetnick N, Ljunggren HG. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J. Immunol. 165:3099-104
111. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685-91
112. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-18
113. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-16
114. -/- mice: an overview. J. Leukoc. Biol. 61:389-96
115. + T helper cells. Cell 126:1121-33
116. Winoto A, Littman DR. 2002. Nuclear hormone receptors in T lymphocytes. Cell 109(Suppl.):S57-66
117. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR. 2004. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5:64-73
118. + cells. Science 305:248-51
119. Deleted in proof
120. Robinson DS, O'Garra A. 2002. Further checkpoints in Th1 development. Immunity 16:755-58
121. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645-55
122. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176:237-47
123. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929-36
124. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-45
125. Trinchieri G, Pflanz S, Kastelein RA. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641-44
126. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, et al. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172:2225-31
127. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, et al. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103:8137-42
128. Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, et al. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203:1105-16
129. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, et al. 2006. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203:843-49
130. Veldhoen M, Stockinger B. 2006. TGFβ1, a "Jack of all trades": the link with proinflammatory IL-17-producing T cells. Trends Immunol. 27:358-61
131. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, et al. 2004. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351:2069-79
132. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev. 19:2783-810
133. Li MO, Wan YY, Sanjabi S, Robertson AL, Flavell RA. 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24:99-146
134. Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25:221-42